Becky Butler Cap
Senior Vice President, BioBridge Global
Becky Cap, a 20-year veteran of the life sciences industry, was named chief operating officer of San Antonio-based GenCure in February, 2016. In her position, Cap founded and has advanced the development of GenCure’s biomanufacturing facilities and capabilities to help fulfill the mission of realizing the potential of donated human cells and tissue to save and enhance lives.
Her philosophy of innovation through collaboration informs her operating approach within BioBridge Global and with GenCure’s customers. Cap, a native of Texas, earned a bachelor’s degree from Harvard University. She began her career at Dana-Farber Cancer Institute in Boston, where she gained clinical, laboratory and regulatory experience.
While pursuing her MBA at Boston University’s Health Care Management Program, she began her career in consulting with Eidetics, a firm focused on informing biomedical product development, where her focus was largely on the emerging oncology market. She also has run her own consulting firm and worked with startups local to San Antonio.
Cap has provided strategic guidance for the development of pharmaceuticals and extensive entrepreneurial coaching. She is an active member of local and national committees on Regenerative Medicine and Cell Therapy. Additionally, Cap is a co-founder and was the founding president of San Antonio TechBoosters, a 501(c)6 organization established to mentor student entrepreneurs.Read more
Michael J. Fiske
Mike Fiske has more than 30 years in the biotechnology industry as a protein chemist, analytical biochemist, process development scientist and cGMP operations manager. He serves as Vice President, Biomanufacturing at GenCure, which operates a multi-use, cGMP-compliant, contract manufacturing facility designed for the development and manufacture of advanced therapies.
He has extensive background in cGMP compliance, including manufacturing facility design, construction and validation. Mike also has extensive experience in biologics process development, analytical test method development, and validation, as well as cGMP manufacturing and QC release testing of clinical-grade biologics including vaccines, protein therapeutics and cell therapy products.
As Vice President, Mike is responsible for the ongoing facility operations including new facility construction and validation, technology transfer, clinical-scale process and analytical methods development, cGMP manufacturing and QC testing of preclinical and clinical-grade cell-based products. He also provides assistance to clients with preparation of regulatory documents and interactions with regulatory agencies as needed.Read more
A 25-year industry veteran, Christie Malone is the Business Development Director at GenCure. Malone focuses on advancing the organization’s strategic collaborations with not only therapeutic cell and cell & gene therapy companies in every stage of the product development pipeline, but also the companies that provide tools to facilitate clinical product manufacturing.
Since joining GenCure in 2017, Malone has established GenCure as a preferred contract development and manufacturing organization for the cell and gene therapy marketplace, ensuring client satisfaction and enduring trust as a long-term partner.
Her current role relies on more than 2 decades experience in transfusion medicine, which includes pediatric transfusion practice, blood center immunohematology and infectious disease testing. She also has experience in sales and marketing of 510(k)-regulated, closed-system medical devices.Read more